CRISPR cancer trial success paves the way for personalized treatments

Heidi Ledford

Nature, 2022, vol. 611, issue 7936, 433-434

Abstract: ‘Most complicated therapy ever’ tailors bespoke, genome-edited immune cells to attack tumours.

Keywords: Medical research; CRISPR-Cas9 genome editing; Cancer (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-022-03676-7 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:611:y:2022:i:7936:d:10.1038_d41586-022-03676-7

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-022-03676-7

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().